1. Home
  2. CLDX vs MSEX Comparison

CLDX vs MSEX Comparison

Compare CLDX & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • MSEX
  • Stock Information
  • Founded
  • CLDX N/A
  • MSEX 1897
  • Country
  • CLDX United States
  • MSEX United States
  • Employees
  • CLDX N/A
  • MSEX 360
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MSEX Water Supply
  • Sector
  • CLDX Health Care
  • MSEX Utilities
  • Exchange
  • CLDX Nasdaq
  • MSEX Nasdaq
  • Market Cap
  • CLDX 1.2B
  • MSEX 1.1B
  • IPO Year
  • CLDX 2008
  • MSEX N/A
  • Fundamental
  • Price
  • CLDX $19.44
  • MSEX $62.21
  • Analyst Decision
  • CLDX Buy
  • MSEX Hold
  • Analyst Count
  • CLDX 8
  • MSEX 4
  • Target Price
  • CLDX $54.29
  • MSEX $59.33
  • AVG Volume (30 Days)
  • CLDX 856.2K
  • MSEX 194.5K
  • Earning Date
  • CLDX 05-05-2025
  • MSEX 05-01-2025
  • Dividend Yield
  • CLDX N/A
  • MSEX 2.15%
  • EPS Growth
  • CLDX N/A
  • MSEX 39.94
  • EPS
  • CLDX N/A
  • MSEX 2.47
  • Revenue
  • CLDX $7,020,000.00
  • MSEX $191,877,000.00
  • Revenue This Year
  • CLDX N/A
  • MSEX $10.20
  • Revenue Next Year
  • CLDX N/A
  • MSEX $6.56
  • P/E Ratio
  • CLDX N/A
  • MSEX $25.58
  • Revenue Growth
  • CLDX 1.99
  • MSEX 15.40
  • 52 Week Low
  • CLDX $14.40
  • MSEX $47.40
  • 52 Week High
  • CLDX $47.00
  • MSEX $70.73
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 54.30
  • MSEX 53.83
  • Support Level
  • CLDX $17.45
  • MSEX $61.50
  • Resistance Level
  • CLDX $20.36
  • MSEX $63.80
  • Average True Range (ATR)
  • CLDX 1.21
  • MSEX 2.01
  • MACD
  • CLDX 0.44
  • MSEX -0.24
  • Stochastic Oscillator
  • CLDX 81.21
  • MSEX 40.89

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

Share on Social Networks: